Rarity Bioscience raises €2,5M in seed funding to improve cancer care

Linus Bosaeus, CEO Rarity Bioscience

With the aim to improve cancer diagnostics, Rarity Bioscience has raised €2,5 million to expand operations and product development within precision diagnostics and liquid biopsy. The seed round was led by founders and joined by new investor, Navigare Ventures, owned by Wallenberg Investments AB. This investment round has come after a successful first year establishing […]